About
David Grainger is a Partner at Medicxi, a venture capital firm focused on investing in early-stage life science companies. Medicxi operates under a unique 'asset-centric' investment model, aiming to develop and finance single-asset companies with the potential for significant value creation. David's role involves identifying and evaluating promising investment opportunities within the biopharmaceutical sector. His past experience and expertise contribute to Medicxi's mission of advancing innovative therapies and improving patient outcomes.
Sign up to see David Grainger's full profile
Access investment thesis, focus areas, bio, and contact details for David Grainger and 22,000+ other VC professionals.
Medicxi
London, GB